The anti-AD effect of baicalin also depends on the gut microbiota because fecal transplantation from baicalin-treated mice to GF (germ-free) mice resulted in significantly reduced skin thickness and clinical symptoms accompanied by decreased serum IgE and IL-4 [104]. Here, IGHE is linked to Alzheimer disease.